Sanofi-Aventis (France) to Probe Cancer Link with Insulin Use

Bookmark and Share

Reuters -- Sanofi Aventis on Tuesday launched a research plan to probe the safety of insulin, including its Lantus diabetis drug.
MORE ON THIS TOPIC